Total Payments
$1,684
2023 Payments
$328.81
Companies
24
Transactions
101
Medicare Patients
1,866
Medicare Billing
$150,715
Payment Breakdown by Category
Food & Beverage$1,684 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,684 | 101 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $235.37 | 15 | $0 (2023) |
| Novo Nordisk Inc | $207.96 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $205.46 | 14 | $0 (2023) |
| ABBVIE INC. | $182.81 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $160.17 | 9 | $0 (2023) |
| PFIZER INC. | $121.31 | 6 | $0 (2023) |
| Lilly USA, LLC | $76.81 | 5 | $0 (2023) |
| Merck Sharp & Dohme LLC | $62.73 | 4 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $57.82 | 4 | $0 (2023) |
| Abbott Laboratories | $49.30 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $328.81 | 19 | GlaxoSmithKline, LLC. ($63.86) |
| 2022 | $873.49 | 51 | ABBVIE INC. ($151.68) |
| 2021 | $481.73 | 31 | Boehringer Ingelheim Pharmaceuticals, Inc. ($72.33) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Neuroscience | ||||||
| 05/11/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: VTE | ||||||
| 04/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Neuroscience | ||||||
| 04/19/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Obesity | ||||||
| 03/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/22/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.11 | General |
| 02/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/26/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: VACCINES | ||||||
| 01/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: RESPIRATORY | ||||||
| 01/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: DIABETES | ||||||
| 01/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/11/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/01/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: INSOMNIA | ||||||
| 11/29/2022 | Merck Sharp & Dohme LLC | STEGLUJAN (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/23/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2022 | PFIZER INC. | COMIRNATY (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: VACCINES | ||||||
| 11/15/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Urology | ||||||
| 11/08/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 375 | 555 | $187,557 | $32,430 |
| 2022 | 10 | 484 | 694 | $179,687 | $41,458 |
| 2021 | 13 | 480 | 647 | $162,875 | $38,562 |
| 2020 | 15 | 527 | 796 | $198,635 | $38,265 |
Total Patients
1,866
Total Services
2,692
Medicare Billing
$150,715
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 272 | $117,918 | $19,354 | 16.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 48 | 48 | $22,180 | $5,242 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 77 | $22,759 | $3,650 | 16.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 32 | 32 | $11,504 | $1,993 | 17.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 56 | 56 | $4,580 | $879.20 | 19.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 44 | 44 | $3,624 | $690.80 | 19.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 11 | 12 | $4,122 | $488.94 | 11.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 14 | $870.00 | $133.28 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 334 | $105,210 | $23,344 | 22.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 45 | 45 | $14,850 | $5,044 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 98 | $21,070 | $4,722 | 22.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 64 | 65 | $17,225 | $3,639 | 21.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $6,930 | $1,996 | 28.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 66 | 66 | $3,630 | $1,067 | 29.4% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 11 | 11 | $4,400 | $521.84 | 11.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 17 | 17 | $3,757 | $521.64 | 13.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 31 | 31 | $1,705 | $493.30 | 28.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $910.00 | $107.70 | 11.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 282 | $88,830 | $21,897 | 24.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $13,530 | $4,696 | 34.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 95 | $20,425 | $4,519 | 22.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 38 | 38 | $10,070 | $2,287 | 22.7% |
| 93923 | Ultrasound study of arteries of both arms and legs, complete | Office | 2021 | 15 | 15 | $8,625 | $1,197 | 13.9% |
| 93922 | Ultrasound study of arteries of both arms and legs, limited | Office | 2021 | 16 | 16 | $6,400 | $843.78 | 13.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 46 | 46 | $2,530 | $748.88 | 29.6% |
About Carl Dear, PAC
Carl Dear, PAC is a Physician Assistant healthcare provider based in Mesquite, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003856717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Carl Dear, PAC has received a total of $1,684 in payments from pharmaceutical and medical device companies, with $328.81 received in 2023. These payments were reported across 101 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,684).
As a Medicare-enrolled provider, Dear has provided services to 1,866 Medicare beneficiaries, totaling 2,692 services with total Medicare billing of $150,715. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Mesquite, TX
- Active Since 06/08/2006
- Last Updated 07/09/2007
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1003856717
Products in Payments
- FARXIGA (Drug) $188.15
- TRELEGY ELLIPTA (Drug) $152.24
- JARDIANCE (Drug) $142.74
- VRAYLAR (Drug) $107.82
- Rybelsus (Drug) $71.90
- Ozempic (Drug) $65.41
- XARELTO (Drug) $57.82
- SHINGRIX (Biological) $57.05
- ELIQUIS (Drug) $48.58
- Vascepa (Drug) $42.37
- QULIPTA (Drug) $40.89
- EMGALITY (Drug) $36.23
- COMIRNATY (Biological) $36.17
- UBRELVY (Drug) $34.10
- FREESTYLE LIBRE 2 (Device) $33.48
- STEGLUJAN (Drug) $30.55
- TRINTELLIX (Drug) $30.49
- NURTEC ODT (Drug) $27.95
- TRULICITY (Drug) $26.18
- Diamondback Peripheral (Device) $24.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Mesquite
Lillian Wang
Physician Assistant — Payments: $12,662
Physician Assistant $12,662
Wendy Fasano, Pa, PA
Physician Assistant — Payments: $9,677
Physician Assistant $9,677
Alexandra Hoeger
Physician Assistant — Payments: $7,237
Physician Assistant $7,237
Nathan Yeh
Physician Assistant — Payments: $4,236
Physician Assistant $4,236
Evan Conrad, Pa, PA
Physician Assistant — Payments: $4,026
Physician Assistant $4,026
Katherine Schultheiss, Pa, PA
Physician Assistant — Payments: $3,986
Physician Assistant $3,986